Adamis Pharmaceuticals reported $1.24M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
Adma Biologics USD 206.46M 9.8M Dec/2025
Cara Therapeutics USD 900K 0 Mar/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Grifols EUR 3.56B 63.19M Dec/2024
Merck USD 6.44B 157M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
RedHill Biopharma USD 3.17M 482K Jun/2025